KuartisMED
Signal active
Organization
Contact Information
Overview
KuartisMED is a biomedical company developing products for the well-being of preterm infants. It developed Premades, a monitoring feeding ability for newborns.
KuartisMED is a proud Horizon 2020 SME Instrument grantee. Its banner product has received a Phase-2 grant for the “SMEInst-12-2016-2017 — New business models for inclusive, innovative and reflective societies” which is awarded from the European Union’s Horizon 2020 research and innovation program. The company had previously received H2020 SME Instrument Phase-1 grant in 2014 for the Feasibility Study and Commercialization Plan for PREMADES.
About
Industries
Biotechnology, Medical, Medical Device, Baby
Founded
2014
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
KuartisMED headquartered in Europe, operates in the Biotechnology, Medical, Medical Device, Baby sector. The company focuses on Biotechnology and has secured $163.1M in funding across 48 round(s). With a team of 1-10 employees, KuartisMED is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - KuartisMED, raised $1.8M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
9
Lead Investors
0
Total Funding Amount
$3.4M
Details
1
KuartisMED has raised a total of $3.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 1.8M |
Investors
KuartisMED is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Techmine | - | FUNDING ROUND - Techmine | 1.8M |
| Turkey Development Fund | - | FUNDING ROUND - Turkey Development Fund | 1.8M |
| KuartisMED | - | FUNDING ROUND - KuartisMED | 1.8M |
| CVentures | - | FUNDING ROUND - CVentures | 1.8M |
Recent Activity
There is no recent news or activity for this profile.